Folgen
hayley gershengorn
hayley gershengorn
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei med.miami.edu
Titel
Zitiert von
Zitiert von
Jahr
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ...
JAMA internal medicine 180 (11), 1436-1447, 2020
9422020
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19
S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ...
JAMA internal medicine 181 (1), 41-51, 2021
5082021
A tale of two futures: HIV and antiretroviral therapy in San Francisco
SM Blower, HB Gershengorn, RM Grant
Science 287 (5453), 650-654, 2000
4662000
Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising …
WH Self
MMWR. Morbidity and mortality weekly report 70, 2021
4572021
Comparisons of the variability of three markers of the human circadian pacemaker
EB Klerman, HB Gershengorn, JF Duffy, RE Kronauer
Journal of biological rhythms 17 (2), 181-193, 2002
4282002
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
JX Velasco-Hernandez, HB Gershengorn, SM Blower
The Lancet infectious diseases 2 (8), 487-493, 2002
2802002
Predicting the unpredictable: transmission of drug-resistant HIV
SM Blower, AN Aschenbach, HB Gershengorn, JO Kahn
Nature medicine 7 (9), 1016-1020, 2001
2782001
Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021
MW Tenforde
MMWR. Morbidity and mortality weekly report 70, 2021
2482021
Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States
JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ...
American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021
2452021
Association between US norepinephrine shortage and mortality among patients with septic shock
E Vail, HB Gershengorn, M Hua, AJ Walkey, G Rubenfeld, H Wunsch
Jama 317 (14), 1433-1442, 2017
1952017
Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States
MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ...
MedRxiv, 2021
1572021
Staged implementation of awakening and breathing, coordination, delirium monitoring and management, and early mobilization bundle improves patient outcomes and reduces hospital …
SJ Hsieh, O Otusanya, HB Gershengorn, AA Hope, C Dayton, D Levi, ...
Critical care medicine 47 (7), 885-893, 2019
1492019
Remdesivir for severe covid-19: a clinical practice guideline
B Rochwerg, A Agarwal, L Zeng, YS Leo, JA Appiah, T Agoritsas, ...
bmj 370, 2020
1452020
Impact of nonphysician staffing on outcomes in a medical ICU
HB Gershengorn, H Wunsch, R Wahab, D Leaf, D Brodie, G Li, P Factor
Chest 139 (6), 1347-1353, 2011
1302011
Variation in use of intensive care for adults with diabetic ketoacidosis
HB Gershengorn, TJ Iwashyna, CR Cooke, DC Scales, JM Kahn, ...
Critical care medicine 40 (7), 2009-2015, 2012
1202012
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States
MZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, ...
American Journal of Transplantation 20 (11), 3061-3071, 2020
1122020
Variation of arterial and central venous catheter use in United States intensive care units
HB Gershengorn, A Garland, A Kramer, DC Scales, G Rubenfeld, ...
Anesthesiology 120 (3), 650-664, 2014
1102014
Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States …
MW Tenforde
MMWR. Morbidity and mortality weekly report 71, 2022
892022
Staffing in ICUs: physicians and alternative staffing models
A Garland, HB Gershengorn
Chest 143 (1), 214-221, 2013
872013
Association of intensive care unit patient-to-intensivist ratios with hospital mortality
HB Gershengorn, DA Harrison, A Garland, ME Wilcox, KM Rowan, ...
JAMA internal medicine 177 (3), 388-396, 2017
852017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20